One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Cone Structure and Function in RPGR- and USH2A-Associated Retinal Degeneration
doi : 10.1016/j.ajo.2023.01.006
Volume 250, June 2023, Pages 1-11
Cost and Prescriber and Patient Characteristics of Cenegermin Use in the Medicare Population
XI DAI, ADRIANNA JENSEN, CHEN DUN, SEZEN KARAKUS, FATEMEH RAJAII, AND FASIKA WORETA
doi : 10.1016/j.ajo.2023.01.025
Volume 250, June 2023, Pages 12-19
The blinqâ„¢ Vision Screener in Detection of Amblyopia and Strabismus
SAVANNAH REAVES MONAHAN, SAMANTHA M. SMITH, ELIZABETH THOMPSON GAMMELTOFT, RUPAL H. TRIVEDI, M. EDWARD WILSON, JAMES D. BOWSHER, AND MAE MILLICENT W. PETERSEIM
doi : 10.1016/j.ajo.2023.01.013
Volume 250, June 2023, Pages 20-24
Clinical Evaluation of Reading Performance in Refractive Lens Exchange With a Diffractive Continuous-Range-of-Vision Intraocular Lens
ISABELLA D. BAUR, GERD U. AUFFARTH, GRZEGORZ ?ABUZ, ANNETTE STENGELE, MUSTAFA K. HALLAK, AND RAMIN KHORAMNIA
doi : 10.1016/j.ajo.2023.01.011
Volume 250, June 2023, Pages 25-37
Geometric Deep Learning to Identify the Critical 3D Structural Features of the Optic Nerve Head for Glaucoma Diagnosis
FABIAN A. BRAEU, ALEXANDRE H. THIERY, TIN A. TUN, AISTE KADZIAUSKIENE, GEORGE BARBASTATHIS, TIN AUNG, AND MICHAEL J.A. GIRARD
doi : 10.1016/j.ajo.2023.01.008
Volume 250, June 2023, Pages 38-48
The Impact of Neighborhood Factors on Physical Activity in Older Adults With Visual Impairment
CATALINA GARZON, ALEKSANDRA MIHAILOVIC, JIAN-YU E, SHEILA K. WEST, LAURA N. GITLIN, DAVID S. FRIEDMAN, AND PRADEEP Y. RAMULU
doi : 10.1016/j.ajo.2023.01.017
Volume 250, June 2023, Pages 49-58
Long-term Safety and Efficacy of Corneal Collagen Crosslinking in a Pediatric Group With Progressive Keratoconus: A 7-year Follow-up
J?LIA POLIDO, MARIA EM?LIA XAVIER DOS SANTOS ARA?JO, TAIS H. WAKAMATSU, JO?O G. ALEXANDER, THIAGO CABRAL, RENATO AMBR?SIO JR, AND DENISE FREITAS
doi : 10.1016/j.ajo.2023.01.012
Volume 250, June 2023, Pages 59-69
Defining the Phenotype and Prognosis of People With Idiopathic Intracranial Hypertension After Cerebrospinal Fluid Diversion Surgery
YOUSEF F. HYDER, VICTORIA HOMER, MARK THALLER, MARIAN BYRNE, GEORGIOS TSERMOULAS, RACHEL PICCUS, SUSAN P. MOLLAN, AND ALEXANDRA J. SINCLAIR
doi : 10.1016/j.ajo.2023.01.016
Volume 250, June 2023, Pages 70-81
An All-in-One Highly Multiplexed Diagnostic Assay for Rapid, Sensitive, and Comprehensive Detection of Intraocular Pathogens
PAULO J.M. BISPO, NICOLE BELANGER, ASHLEY LI, RENEE LIU, GAYATRI SUSARLA, WEILIN CHAN, JAMES CHODOSH, MICHAEL S. GILMORE, AND LUCIA SOBRIN
doi : 10.1016/j.ajo.2023.01.021
Volume 250, June 2023, Pages 82-94
Corneal Crosslinking With Riboflavin and UVA Light in Progressive Keratoconus: Fifteen-Year Results
FREDERIK RAISKUP, ROBERT HERBER, JANINE LENK, LISA RAMM, DIERK WITTIG, LUTZ E. PILLUNAT, AND EBERHARD SPOERL
doi : 10.1016/j.ajo.2023.01.022
Volume 250, June 2023, Pages 95-102
Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years
JACQUE L. DUNCAN, PEIYAO CHENG, MAUREEN G. MAGUIRE, ALLISON A. AYALA, DAVID G. BIRCH, JANET K. CHEETHAM, TODD A. DURHAM, ABIGAIL T. FAHIM, CAREL B. HOYNG, HIROSHI ISHIKAWA, MICHEL MICHAELIDES, MARK E. PENNESI, JOSE-ALAIN SAHEL, KATARINA STINGL, AND CHRISTINA Y. WENG, ON BEHALF OF THE FOUNDATION FIGHTING BLINDNESS CONSORTIUM INVESTIGATOR GROUP
doi : 10.1016/j.ajo.2023.02.002
Volume 250, June 2023, Pages 103-110
Retinal Vascular Occlusion Risks in High Blood Pressure and the Benefits of Blood Pressure Control
HAE RANG KIM, NANG KYEONG LEE, CHRISTOPHER SEUNGKYU LEE, SUK HO BYEON, SUNG SOO KIM, SEUNG WON LEE?, AND YONG JOON KIM?
doi : 10.1016/j.ajo.2023.01.023
Volume 250, June 2023, Pages 111-119
Ambulatory Monitoring With Eye Tracking Glasses to Assess the Severity of Intermittent Exotropia
JOHN R. ECONOMIDES, MIKAYLA D. DILBECK, THOMAS N. GENTRY, AND JONATHAN C. HORTON
doi : 10.1016/j.ajo.2023.01.014
Volume 250, June 2023, Pages 120-129
Identifying Risk Factors for Blindness From Glaucoma at First Presentation to a Tertiary Clinic
ALYSSA SHI, SAMUEL I. BERCHUCK, ALESSANDRO A. JAMMAL, GEETIKA SINGH, SYDNEY HUNT, KIMBERLY ROCHE, SAYAN MUKHERJEE, AND FELIPE A. MEDEIROS
doi : 10.1016/j.ajo.2023.02.006
Volume 250, June 2023, Pages 130-137
In Vivo Corneal Confocal Microscopy in Multiple Sclerosis: Can it Differentiate Disease Relapse in Multiple Sclerosis?
VOLKAN DERICIO ?GLU, SEMRA AKKAYA TURHAN, HALIT EREN ERDEM, MEHMET ORKUN SEVIK, ESRA ERDIL, GULIN SUNTER, KADRIYE A ?GAN, AND EBRU TOKER
doi : 10.1016/j.ajo.2023.01.015
Volume 250, June 2023, Pages 138-148
Rotational Stability, Decentration, and Tilt of a New Hydrophobic Acrylic Intraocular Lens Platform
VERONIKA R?GGLA, DANIEL SCHARTMULLER, LUCA SCHWARZENBACHER, CHRISTINA LEYDOLT, AND RUPERT MENAPACE
doi : 10.1016/j.ajo.2023.01.026
Volume 250, June 2023, Pages 149-156
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17)
RUPERT W. STRAUSS, ALEXANDER HO, ANAMIKA JHA, KAORU FUJINAMI, MICHEL MICHAELIDES, ARTUR V. CIDECIYAN, ISABELLE AUDO, DAVID G. BIRCH, SRINIVAS SADDA, MICHAEL IP, SHEILA WEST, ETIENNE M. SCH?NBACH, XIANGRONG KONG, AND HENDRIK P.N. SCHOLL, ON BEHALF OF THE PROGSTAR STUDY GROUP
doi : 10.1016/j.ajo.2023.02.003
Volume 250, June 2023, Pages 157-170
Characteristics of 110 Patients With Functional Visual Loss
IRINA SVERDLICHENKO, NATALIE BROSSARD-BARBOSA, JONATHAN A. MICIELI, AND EDWARD MARGOLIN
doi : 10.1016/j.ajo.2023.02.005
Volume 250, June 2023, Pages 171-176
Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma
RAFFAEL LIEGL, VALERIE SCHMELTER, CHRISTOPH FUERWEGER, FELIX EHRET, SIEGFRIED PRIGLINGER, ALEXANDER MUACEVIC, AND PAUL FOERSTER
doi : 10.1016/j.ajo.2022.12.021
Volume 250, June 2023, Pages 177-185
Comment on: Perspective: A Caveat About Financial Incentives for Anti−vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
JAMES F. VANDER? MITCHELL S. FINEMAN SUNIR GARG CARL D. REGILLO
doi : 10.1016/j.ajo.2023.01.029
Volume 250, June 2023, Pages 186-187
Response to “Comment on: Perspective: A Caveat About Financial Incentives For Anti-Vascular Endothelial Growth Factor Therapy For Diabetic Retinopathy�
BENJAMIN K. YOUNG MIN HWANG MARK W. JOHNSON CAGRI G. BESIRLI THOMAS J. WUBBEN
doi : 10.1016/j.ajo.2023.02.015
Volume 250, June 2023, Pages 188-189
Comment on: A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
SESHUBABU GOSALA
doi : 10.1016/j.ajo.2022.12.029
Volume 250, June 2023, Pages 190-191
Reply to Comment on: “A Caveat about Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy�
BENJAMIN K. YOUNG MIN HWANG MARK W. JOHNSON CAGRI G. BESIRLI THOMAS J. WUBBEN
doi : 10.1016/j.ajo.2023.01.009
Volume 250, June 2023, Pages 192-193
Comment on: Systematic Review and Meta-Analysis: Outcomes After Descemet Membrane Endothelial Keratoplasty Versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty
GEORGIOS S. DIMTSASMICHAELTSATSOSMARILITA M. MOSCHOS
doi : 10.1016/j.ajo.2022.11.027
Volume 250, June 2023, Pages 194-195
Reply to comment on: Systematic Review and Meta-Analysis: Outcomes After Descemet Membrane Endothelial Keratoplasty Versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty
ANNA-KARINA B. MAIER?, JONAS MILEK, ANTONIAM. JOUSSEN, TINA DIETRICH-NTOUKASGREGOR LICHTNER
doi : 10.1016/j.ajo.2022.12.002
Volume 250, June 2023, Pages 196-197
Ipilimumab and Nivolumab for Treatment of Eyelid Spindle Cell Melanoma
MARISSA K. SHOJI AND ANDREW J. RONG
doi : 10.1016/j.ajo.2023.02.010
Volume 250, June 2023, Pages e1-e2
